Trans Genic Inc.

53
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3635720000
JPY
208.00
-1 (-0.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Trans Genic Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
-207.00
-675.00
43.00
-331.00
2,767.00
695.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
218.00
253.00
-659.00
-958.00
-47.00
180.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
25.00
94.00
-392.00
-1,430.00
1,789.00
1,222.00
Cash Flow from Investing Activities
50.00
-287.00
-280.00
-216.00
981.00
48.00
Cash Flow from Financing Activities
-518.00
265.00
-342.00
484.00
-1,183.00
10.00
Net Cash Inflow / Outflow
-441.00
75.00
-993.00
-1,159.00
1,588.00
1,280.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
4.00
22.00
1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Trans Genic Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
-207.439
72.867
-279.00
-384.68%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
218.089
897.505
-679.00
-75.70%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
25.91
936.707
-911.00
-97.23%
Cash Flow from Investing Activities
50.874
65.077
-15.00
-21.82%
Cash Flow from Financing Activities
-518.46
-240.061
-278.00
-115.97%
Net Cash Inflow / Outflow
-441.528
764.022
-1,205.00
-157.79%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.148
2.299
-2.00
-93.56%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
stock-summary

YoY Growth in year ended Mar 2026 is -72.46% vs 123.98% in Mar 2025

Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
25.91
94.10
-72.46%